nStrada Gen 2

About NanoMedical Systems

NanoMedical Systems is a private, pre-revenue biotech firm pioneering a novel nanofluidics-based drug delivery platform called nStrada™. Founded in 2009 and headquartered in Austin, Texas, the company is developing subcutaneous implants designed to provide steady, tunable, and long-lasting release of therapeutics from weeks to over a year. Its technology aims to overcome limitations of existing depots, such as burst release and delayed steady-state, and is applicable to a broad spectrum of molecules, including small molecules, peptides, and proteins. The company is currently in the preclinical development stage, advancing multiple generations of its implant system.